Menopause Supplements: What the Evidence Actually Shows

Last week we talked about the neuroscience of sleep disruption in menopause, why CBT-I works when other approaches fall short, and how to interpret what your wearable is actually measuring. This week I want to tackle something that comes up in almost every appointment I have: supplements.

The supplement industry has found a lucrative home in the menopause space. Globally, the menopause market is valued at over $17 billion and growing, with dietary supplements claiming the largest share. Celebrity-endorsed "menopause support" blends are everywhere, and social media has become a relentless channel for testimonials dressed up as clinical evidence. The phenomenon even has a name now: menowashing, which refers to the practice of marketing products as capable of providing menopause relief without any meaningful scientific evidence behind them.

I want to give you a framework for evaluating these claims, and then walk through what the evidence actually shows for some of the most commonly discussed supplements.

What Supplement Regulations Mean for Menopausal Women

Before we look at individual compounds, it helps to understand the landscape they exist in. Prescription medications and FDA-approved hormone therapy go through rigorous pre-market clinical trials demonstrating safety and efficacy. Dietary supplements do not. Under the Dietary Supplement Health and Education Act of 1994, the FDA cannot require pre-market approval for supplements. The manufacturer is responsible for ensuring safety, but that burden is largely self-policed, and the FDA steps in only after problems are reported.

This has two important practical consequences. First, there is no guarantee that what is on the label is what is in the bottle, in the stated concentration. Second, there is no mechanism forcing companies to prove their products work before selling them. Supplement companies are also prohibited from claiming their products treat a disease, which is why you will never see a label that says "treats hot flashes." Instead, you see language like "supports hormonal balance" or "promotes comfort during the change." These are structure-function claims, and they require no clinical evidence at all.

The consumer advocacy organization TINA.org has documented thousands of examples of menopause supplement companies crossing that line in their broader marketing, explicitly promising relief from hot flashes, insomnia, anxiety, and low libido, without evidence to back it up.

This doesn't mean nothing in the supplement aisle has any evidence behind it. It means you need a different lens for evaluating each one. And "natural" is not that lens. Kava, for example, is a plant derived from the pepper family. It can cause serious liver damage. "Natural" on a label is marketing, not a safety assurance.

Why Clinical Trials Matter When Evaluating Menopause Supplements

Women have been told for decades that their symptoms are exaggerated, emotional, or imagined. Hot flashes are not. Night sweats are not. Sleep disruption is not. These are real, measurable physiological events, and the suffering they cause is well-documented. None of what follows about study design is meant to suggest otherwise.

What study design helps us figure out is not whether your symptoms are real, but whether a specific treatment is actually responsible for relieving them. That distinction matters enormously in menopause research, because something genuinely unusual happens in clinical trials in this space: women who receive a placebo, an inactive look-alike treatment, typically report 25 to 50 percent improvement in their hot flash frequency and severity. Both the treatment group and the placebo group improve. The question a well-designed trial answers is whether the treatment works better than the placebo. If it doesn't, the active compound isn't doing the work.

This is why a placebo-controlled trial is not optional, and why "before and after" product testimonials, no matter how compelling, cannot tell you whether the product is the reason someone felt better.

The story of magnesium and hot flashes is a perfect illustration. An early trial of 25 postmenopausal women found that magnesium reduced hot flash frequency by over 40 percent. That looks impressive. The problem: there was no placebo group in that study, so there was no way to separate the effect of magnesium from the effect of simply being in a clinical trial. Researchers at Mayo Clinic then ran a proper placebo-controlled trial with 289 women. Both groups got better. The magnesium wasn't the reason. That same pattern plays out across much of this literature.

Menopause Supplements and Hot Flashes: What the Evidence Shows

The Menopause Society's 2023 position statement reviewed the available evidence and concluded that supplements and botanicals are not recommended for managing hot flashes and night sweats. This is based on evidence that exists and has been reviewed, not a gap in the research. Trials have been conducted and the data have been examined, and the evidence does not support their use for this purpose.'

With that framing, let's look at what the data shows about some of the most popular supplements.

Phytoestrogens: Soy and Red Clover

Phytoestrogens are compounds found in plants that can bind weakly to estrogen receptors in the body. The reasoning behind their use is intuitive: if declining estrogen is driving hot flashes and night sweats, perhaps compounds with mild estrogen-like activity could help. The problem is that the estrogen-like activity in a typical serving of soy or red clover is very low, almost certainly too low to meaningfully affect hot flash physiology for most women.

The clinical evidence reflects this. A thorough 2024 review of 62 randomized controlled trials found mixed results across the board, and when researchers looked only at the highest-quality trials, any positive effect largely disappeared. The few trials that showed some benefit tended to be short-term, and the positive results faded in ways that corresponded with the period when placebo effects are typically at their strongest. Red clover follows the same pattern.

If you enjoy eating whole soy foods, keep doing so. There don't appear to be meaningful safety concerns. The American Cancer Society does not recommend soy supplements, but supports soy foods as part of a healthy diet. High-dose isoflavone supplements are a different matter: while there is no clear evidence of harm from dietary soy, better evidence confirming safety is needed before high-dose isoflavone supplements can be recommended, particularly for women with a history of hormone-sensitive cancers. That uncertainty, combined with the absence of demonstrated benefit for hot flashes or night sweats, makes concentrated isoflavone supplements hard to justify.

Black Cohosh

Black cohosh is the most commonly purchased botanical for menopause symptoms in the United States. The Menopause Society's 2023 statement found insufficient evidence to support its use for hot flashes and night sweats, and that conclusion is based on trials that have been conducted and reviewed, not a lack of data.

Researchers aren't entirely certain how black cohosh acts in the body. Early theories pointed toward estrogen-like effects, but subsequent research hasn't supported that consistently, and more recent work has pointed elsewhere. The mechanism remains genuinely unresolved, which makes interpreting the clinical data harder.

More importantly, there have been case reports of significant liver injury in people taking black cohosh. A definitive causal link hasn't been proven, but the signal is real and concerning. Unlike soy foods, which have a substantial and reassuring human safety record, black cohosh carries a plausible safety question independent of whether it works. When there's no demonstrated benefit and a potential safety concern, the case for taking it is hard to make.

Vitamin D and Menopause: Does Bone Health Evidence Hold Up?

Want to read more?

Subscribe to purelymenopause.com to keep reading this exclusive post.

Subscribe Now